View Document Preview and Link
Document Date: 2013-01-10 14:44:54 Open Document File Size: 159,10 KB Share Result on Facebook
Company PICU / / Country Australia / United Kingdom / / Currency CYP / pence / / Event Product Issues / Product Recall / / Facility National Institute / / IndustryTerm nerve gas / antiAlzheimers pharmaceuticals / treatment for Severe Mental Illness / drug metabolising systems / dopaminergic and serotonergic systems / verbal communications / pharmaceutical / chemicals / / MedicalCondition Organophosphate Exposure Neuroleptic Malignant Syndrome / agitation Akathisia / violence Muscle rigidity Muscle breakdown Coma / Cranial nerve palsy / schizophrenia / emotional restlessness / violence Restlessness Restlessness / akathisia Agitation Clozaril Olanzapine Palperidone/Invega Quetiapine Risperidone Sertindole Zotepine Akathisia / akathisia Restlessness / Chronic / consciousness Dementia / Violence Abilify Amisulpride Restlessness / mania / chronic Organophosphate Poisoning / consciousness Confusion Fever Aggression Paralysis / low blood pressure / Serotonin Syndrome / Severe Mental Illness / drooling / serotonin toxicity/akathisia / schizophrenia /bipolar illness / Neuroleptic Malignant Syndrome / restlessness / Dystonia / high blood pressure / agitation Restlessness / aggression Akathisia / akathisia induction / Organophosphate Poisoning / command hallucinations / respiratory distress / akathisia / Violence Organophosphate Poisoning / / MedicalTreatment drug prescriptions / Polypharmacy / / Organization National Institute for Health and Clinical Excellence / / Person Catherine Clarke / Jan Evans / / Position author / guard / / Product Neuroleptic / Olanzapine / clozapine / Invega / haloperidol / tripled.12 Neuroleptic / Behaviour There / Stelazine / neuroleptic medication / Risperidone / Abilify / Neuroleptic Drugs / perphenazine / Clozaril / / Technology drug metabolism / Pharmacogenetics / genotype / / URL http / SocialTag